Review





Similar Products

93
OriGene herc6 human tagged orf origene rc218907 dyk herc6 genscript sc1626 myc lats2 addgene 66852 keratinocyte serum free medium thermofisher scientific
Herc6 Human Tagged Orf Origene Rc218907 Dyk Herc6 Genscript Sc1626 Myc Lats2 Addgene 66852 Keratinocyte Serum Free Medium Thermofisher Scientific, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/herc6 human tagged orf origene rc218907 dyk herc6 genscript sc1626 myc lats2 addgene 66852 keratinocyte serum free medium thermofisher scientific/product/OriGene
Average 93 stars, based on 1 article reviews
herc6 human tagged orf origene rc218907 dyk herc6 genscript sc1626 myc lats2 addgene 66852 keratinocyte serum free medium thermofisher scientific - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

93
Addgene inc pclneomyc lats2 plasmid
<t>LATS2</t> is a target gene of miR-25 . (a) The predicted binding site of miR-25 in the 3′UTR of LATS2 from miRBase. The mutated LATS2 3′UTR-binding site is indicated. (b) LATS2 expression in 15 pairs of NSCLC tissues and adjacent normal tissues by qRT-PCR. (c) LATS2 expression in NSCLC cell lines and the noncancerous lung epithelial cell line BEAS-2B. (d) Kaplan-Meier curve for overall survival in lung cancer patients with high or low LATS2 expression. Data were taken from TCGA. (e, f) Luciferase reporter assays in HEK-293 cells. (g, h) Luciferase reporter assays in H1299 cells. HEK-293T, A549, and H1299 cells were cotransfected with pRL-TK carrying a wild-type or mutant 3′UTR of LATS2 and the miR-25 precursor (60 ng) or the miR-25 inhibitor (10 pmol), and the luciferase activity was measured 48 h posttransfection. (i) Western blot assays for LATS2 in A549, H1299, and BEAS-2B cells. (j) Western blot analysis of LATS2 in A549 and H1299 cells transfected with miR-25 precursor or the miR-25 inhibitor. Experiments in this section were performed using our documented protocols . Results were presented as the mean ± SD. ∗ P < 0.05 and ∗∗∗ P < 0.001.
Pclneomyc Lats2 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pclneomyc lats2 plasmid/product/Addgene inc
Average 93 stars, based on 1 article reviews
pclneomyc lats2 plasmid - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

93
Addgene inc myc lats2
( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or <t>Flag-LATS2</t> and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).
Myc Lats2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/myc lats2/product/Addgene inc
Average 93 stars, based on 1 article reviews
myc lats2 - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

93
Addgene inc lats2 gene
( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or <t>Flag-LATS2</t> and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).
Lats2 Gene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lats2 gene/product/Addgene inc
Average 93 stars, based on 1 article reviews
lats2 gene - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

93
Addgene inc plasmid pclneomyc lats2
( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or <t>Flag-LATS2</t> and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).
Plasmid Pclneomyc Lats2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid pclneomyc lats2/product/Addgene inc
Average 93 stars, based on 1 article reviews
plasmid pclneomyc lats2 - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

93
Addgene inc lats2 expression
( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or <t>Flag-LATS2</t> and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).
Lats2 Expression, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lats2 expression/product/Addgene inc
Average 93 stars, based on 1 article reviews
lats2 expression - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

91
Proteintech xrn2
( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or <t>Flag-LATS2</t> and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).
Xrn2, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xrn2/product/Proteintech
Average 91 stars, based on 1 article reviews
xrn2 - by Bioz Stars, 2025-02
91/100 stars
  Buy from Supplier

93
Addgene inc pcineomyc lats2
( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or <t>Flag-LATS2</t> and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).
Pcineomyc Lats2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcineomyc lats2/product/Addgene inc
Average 93 stars, based on 1 article reviews
pcineomyc lats2 - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

86
Bristol Myers cgp 14 458 cas registry no 66852 54 8 note
( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or <t>Flag-LATS2</t> and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).
Cgp 14 458 Cas Registry No 66852 54 8 Note, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgp 14 458 cas registry no 66852 54 8 note/product/Bristol Myers
Average 86 stars, based on 1 article reviews
cgp 14 458 cas registry no 66852 54 8 note - by Bioz Stars, 2025-02
86/100 stars
  Buy from Supplier

Image Search Results


LATS2 is a target gene of miR-25 . (a) The predicted binding site of miR-25 in the 3′UTR of LATS2 from miRBase. The mutated LATS2 3′UTR-binding site is indicated. (b) LATS2 expression in 15 pairs of NSCLC tissues and adjacent normal tissues by qRT-PCR. (c) LATS2 expression in NSCLC cell lines and the noncancerous lung epithelial cell line BEAS-2B. (d) Kaplan-Meier curve for overall survival in lung cancer patients with high or low LATS2 expression. Data were taken from TCGA. (e, f) Luciferase reporter assays in HEK-293 cells. (g, h) Luciferase reporter assays in H1299 cells. HEK-293T, A549, and H1299 cells were cotransfected with pRL-TK carrying a wild-type or mutant 3′UTR of LATS2 and the miR-25 precursor (60 ng) or the miR-25 inhibitor (10 pmol), and the luciferase activity was measured 48 h posttransfection. (i) Western blot assays for LATS2 in A549, H1299, and BEAS-2B cells. (j) Western blot analysis of LATS2 in A549 and H1299 cells transfected with miR-25 precursor or the miR-25 inhibitor. Experiments in this section were performed using our documented protocols . Results were presented as the mean ± SD. ∗ P < 0.05 and ∗∗∗ P < 0.001.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway

doi: 10.1155/2019/9719723

Figure Lengend Snippet: LATS2 is a target gene of miR-25 . (a) The predicted binding site of miR-25 in the 3′UTR of LATS2 from miRBase. The mutated LATS2 3′UTR-binding site is indicated. (b) LATS2 expression in 15 pairs of NSCLC tissues and adjacent normal tissues by qRT-PCR. (c) LATS2 expression in NSCLC cell lines and the noncancerous lung epithelial cell line BEAS-2B. (d) Kaplan-Meier curve for overall survival in lung cancer patients with high or low LATS2 expression. Data were taken from TCGA. (e, f) Luciferase reporter assays in HEK-293 cells. (g, h) Luciferase reporter assays in H1299 cells. HEK-293T, A549, and H1299 cells were cotransfected with pRL-TK carrying a wild-type or mutant 3′UTR of LATS2 and the miR-25 precursor (60 ng) or the miR-25 inhibitor (10 pmol), and the luciferase activity was measured 48 h posttransfection. (i) Western blot assays for LATS2 in A549, H1299, and BEAS-2B cells. (j) Western blot analysis of LATS2 in A549 and H1299 cells transfected with miR-25 precursor or the miR-25 inhibitor. Experiments in this section were performed using our documented protocols . Results were presented as the mean ± SD. ∗ P < 0.05 and ∗∗∗ P < 0.001.

Article Snippet: The pClneoMyc-LATS2 plasmid was a gift from Yutaka Hata (Addgene plasmid), which expressed Myc-tagged LATS2 in mammalian cells [ ].

Techniques: Binding Assay, Expressing, Quantitative RT-PCR, Luciferase, Mutagenesis, Activity Assay, Western Blot, Transfection

The effects of LATS2 expression on A549 cell proliferation, migration, and invasion. (a) Colony formation of A549 cells transfected with LATS2, miR-25, or the combination of both miR-25 and LATS2 plasmids. (b, c) Wound healing and transwell assays for migration and invasion capacities of A549 cells transfected with miR-25 and/or LATS2. (d) Western blot assays for LATS2, downstream effectors of the Hippo pathway (phosphorylated YAP and YAP), and metastasis-related proteins (E-cadherin, Vimentin, and MMP9) in A549 cells transfected with miR-25 and/or LATS2. Results were presented as the mean ± SD. (e) Immunofluorescence assay for nuclear translocation of YAP protein. Representative immunofluorescent images of YAP staining were shown in the left panel (green: YAP; blue: nuclear; scale bar, 10 μ m). The nuclear localization of YAP is quantified in the right panel by ImageJ software. ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway

doi: 10.1155/2019/9719723

Figure Lengend Snippet: The effects of LATS2 expression on A549 cell proliferation, migration, and invasion. (a) Colony formation of A549 cells transfected with LATS2, miR-25, or the combination of both miR-25 and LATS2 plasmids. (b, c) Wound healing and transwell assays for migration and invasion capacities of A549 cells transfected with miR-25 and/or LATS2. (d) Western blot assays for LATS2, downstream effectors of the Hippo pathway (phosphorylated YAP and YAP), and metastasis-related proteins (E-cadherin, Vimentin, and MMP9) in A549 cells transfected with miR-25 and/or LATS2. Results were presented as the mean ± SD. (e) Immunofluorescence assay for nuclear translocation of YAP protein. Representative immunofluorescent images of YAP staining were shown in the left panel (green: YAP; blue: nuclear; scale bar, 10 μ m). The nuclear localization of YAP is quantified in the right panel by ImageJ software. ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.

Article Snippet: The pClneoMyc-LATS2 plasmid was a gift from Yutaka Hata (Addgene plasmid), which expressed Myc-tagged LATS2 in mammalian cells [ ].

Techniques: Expressing, Migration, Transfection, Western Blot, Immunofluorescence, Translocation Assay, Staining, Software

miR-25 antagomir inhibits lung cancer growth and metastasis in mouse xenografts. (a) Time course of tumor volumes from immunodeficient mice treated with the miR-25 antagomir or a control. Results were presented as the mean ± SD. ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b, c) The image and the weight of xenograft tumors one month after the treatment. Mean ± SD was shown. ∗∗ P < 0.01. (d) Representative images of mouse lungs and livers. (e) Histological morphology of mouse lungs and livers by HE staining. The magnification of the upper row images was 40x, bar scale = 500 μ m. The magnification of the bottom row images was 400x, bar scale = 50 μ m. (f, h) The incidence of lung and liver metastasis in mice after tail intravenous injections with the miR-25 antagomir was shown in the table. (g) Quantification of the metastasis nodules in the lungs of each group ( n = 10). ∗ P < 0.05. (i) Representative images of immunohistochemical analysis of LATS2, E-cadherin, Vimentin, and MMP9 in lung metastasis (magnification, 400x. bar scale = 50 μ m). Brown represented the target protein in IHC, and blue represented nuclear staining.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway

doi: 10.1155/2019/9719723

Figure Lengend Snippet: miR-25 antagomir inhibits lung cancer growth and metastasis in mouse xenografts. (a) Time course of tumor volumes from immunodeficient mice treated with the miR-25 antagomir or a control. Results were presented as the mean ± SD. ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b, c) The image and the weight of xenograft tumors one month after the treatment. Mean ± SD was shown. ∗∗ P < 0.01. (d) Representative images of mouse lungs and livers. (e) Histological morphology of mouse lungs and livers by HE staining. The magnification of the upper row images was 40x, bar scale = 500 μ m. The magnification of the bottom row images was 400x, bar scale = 50 μ m. (f, h) The incidence of lung and liver metastasis in mice after tail intravenous injections with the miR-25 antagomir was shown in the table. (g) Quantification of the metastasis nodules in the lungs of each group ( n = 10). ∗ P < 0.05. (i) Representative images of immunohistochemical analysis of LATS2, E-cadherin, Vimentin, and MMP9 in lung metastasis (magnification, 400x. bar scale = 50 μ m). Brown represented the target protein in IHC, and blue represented nuclear staining.

Article Snippet: The pClneoMyc-LATS2 plasmid was a gift from Yutaka Hata (Addgene plasmid), which expressed Myc-tagged LATS2 in mammalian cells [ ].

Techniques: Staining, Immunohistochemical staining

Schematic presentation of a positive feedback loop involving miR-25/LATS2/YAP/TAZ/TEAD/ MCM7 /miR-25 in lung cancer.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway

doi: 10.1155/2019/9719723

Figure Lengend Snippet: Schematic presentation of a positive feedback loop involving miR-25/LATS2/YAP/TAZ/TEAD/ MCM7 /miR-25 in lung cancer.

Article Snippet: The pClneoMyc-LATS2 plasmid was a gift from Yutaka Hata (Addgene plasmid), which expressed Myc-tagged LATS2 in mammalian cells [ ].

Techniques:

( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or Flag-LATS2 and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).

Journal: Science Advances

Article Title: LATS1 is a central signal transmitter for achieving full type-I interferon activity

doi: 10.1126/sciadv.abj3887

Figure Lengend Snippet: ( A ) IB analysis of IFN-I signaling in HEK293T transfected with HA-LATS1 and treated with IFN-α (1000 IU/ml). ( B ) IB analysis of IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs. ( C ) IB analysis of pY701-STAT1 in HEK293T transfected with shLATS1 and treated with IFN-ɑ (1000 IU/ml). ( D ) IB analysis of pY690-STAT2 (pSTAT2), STAT2, and IRF9 in Lats1/2 +/+ and Lats1/2 −/− MEFs treated with mIFNβ (1000 IU/ml). ( E and F ) IB analysis of pS727-STAT1 in HeLa cells transfected with shLATS1 (E) or in HEK293T transfected with shLATS1 (F) and then treated with IFN-ɑ (1000 IU/ml). ( G and H ) IB analysis of pS727-STAT1 in Lats1/2 +/+ or Lats1/2 −/− MEFs treated with mIFNβ (500 or 1000 IU/ml, 1 hour) (G) or transfected with Flag-LATS1 or Flag-LATS2 and treated with mIFNβ (1000 IU/ml, 1 hour) (H). ( I ) IB analysis of pS727-STAT1 in HEK293T transfected with Flag-LATS1 (WT or YF/YF) and treated with IFN-ɑ (1000 IU/ml, 1 hour). ( J ) RT-qPCR analysis of the representative ISG ( Ifit1 ) in STAT1-WT or STAT1-S727A-knockin 2fTGH cells transfected with shCON or shLATS1, followed by IFN-α treatment (1000 IU/ml, 4 hours) (right). S727A-knockin was confirmed by sequencing (left). ( K ) Median tissue culture infectious dose (TCID 50 ) assay to analyze VSV titers in supernatants from HEK293T transfected with shLATS1 and stimulated with IFN-ɑ (60 IU/ml), followed by VSV infection (multiplicity of infection = 0.1, 24 hours). Data are shown as means and SD of three biological replicates (J to K) or are representative of three independent experiments (A to I). N.S ( P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001 (two-tailed unpaired Student’s t test).

Article Snippet: Myc-LATS2 was a gift from Y. Hata (Addgene, no. 66852).

Techniques: Transfection, Quantitative RT-PCR, Knock-In, Sequencing, Infection, Two Tailed Test